Spinal Muscular Atrophy Type III
3 clinical trials · Condition
◉ Watch Spinal Muscular Atrophy Type III
| Record | Firm | Date |
|---|---|---|
| Spinal Cord Gray Matter Imaging in Spinal Muscular Atrophy (NCT06137612) | University Hospital, Basel, Switzerland | 2020-08-17 |
| Long-term Follow-up Study of Patients Receiving Onasemnogene Abeparvovec-xioi (NCT04042025) | Novartis Gene Therapies | 2020-02-10 |
| Clinical Trial of Sodium Phenylbutyrate in Children With Spinal Muscular Atrophy Types II or III (NCT00439569) | Westat | 2008-01-01 |
Track Spinal Muscular Atrophy Type III automatically
Every clearance here is in the API, with alerts when new ones post.